This study aimed to determine the relationships between happiness and hope with adherence to the treatment regimen among older adults with chronic diseases. In the present study, the participants showed a moderate level of hope, which is in line with the results of studies performed by Balsanelli et al. (
40) but not with a study conducted by Dehbashi et al. on dialysis patients (
41). Higher hope levels among patients with chronic diseases might be attributed to the advances in the care services provided for these patients, including faster diagnosis, increased care levels, and support for disease management (
42). On the other hand, hope is a positive force that enhances motivation, advancement of goals, and compatibility among patients (
43). Bluvol and Ford-Gilboe conducted a study on stroke patients and disclosed that hopeful thinking helped individuals feel that they could control their lives. Therefore, they attributed positive values to their lives and lived more hopefully (
44).
In the current study, the participants had a moderate level of happiness, which is consistent with the findings of a study performed by Abdollahi et al. on hypertensive patients (
45). The results of a study by Petroviˇc et al., who compared happiness levels before and after COVID-19, showed that individuals’ happiness levels did not change significantly at the end of the study. They further explain that loneliness during the pandemic period helps individuals to turn this complicated process into an opportunity by organizing various activities within their homes (
46). On the other hand, the results of some studies show that the pandemic period has had a negative impact on the level of happiness of individuals, especially older individuals, and their anxiety, tension, fatigue, depression, and stress have increased due to the decrease in happiness (
47-
49).
Global surveys conducted before COVID-19 indicate that women typically experience marginally greater happiness than men (
50). The aforementioned data suggest that the null result that was observed might be indicative of a decrease in women’s happiness during COVID-19 (
51). Greyling et al. stated that during the outbreak of COVID-19 and the resulting quarantine, individuals’ happiness levels decreased; however, surprisingly, over time, there appears to be a U-shaped relationship between the number of COVID-19 cases and happiness; that is, at first, the research results show a decrease in the happiness. Nevertheless, due to the nature of COVID-19, its high recovery rate, and low mortality, it seems that the level of happiness has increased. However, the effect size is very small; therefore, this increase is negligible (
52). Since happiness is associated with individuals’ cognitive evaluation of their satisfaction with life, family, job, and experiences of relationships with others, it can represent their mental health (
53).
The participants in the present study showed good adherence to treatment regimens. In a study, Zahetkashan et al. reported that patients with coronary artery disease coped with the threats and challenges caused by the COVID-19 pandemic by targeting their self-care behaviors and tried to adhere to treatments more effectively (
54). The data from Khabbazi et al.’s study showed that medication nonadherence was not common within 6 months after the issue of COVID-19 was widely discussed in the media (
55). In agreement with the results of the current study, Schmeiser et al. reported 90% adherence in the patients receiving antirheumatic medications (
56). Fragoulis et al. reported nonadherence to medications in 14.6% of patients with rheumatic diseases in Greece (
57). However, contradictory results were obtained by Pazokian et al. (
58) in patients with diabetes and by Kavak and Yilmaz (
59) in patients with schizophrenia. Nouira et al. showed that medication nonadherence was reported in 39% of patients in Tunisia, and the predictors of therapeutic nonadherence were polypharmacy, rural origin, and metabolic disease history (
60). Several studies presented that with the continuation of quarantines, social distancing, and economic problems during the COVID-19 pandemic, nonadherence to treatment, especially in older adults, is likely to worsen (
60). However, about 40% of the older adults in this study had moderate to poor adherence to treatment. The rate of adherence to treatment in this study was about 10%. In another study, it was found that 4 - 31% of diabetic patients never tried to prepare their prescribed medicines and some others refused to take medicines after preparing them (
61).
In numerous studies, the prevalence of noncompliance with treatment has been reported within the range of 18 - 71%. This result can be a reason for the hospitalization of 10% of older adults in hospitals and 32% in nursing homes (
61,
62). In another study, it was reported that the adherence to treatment of type 2 diabetes patients in the south of Tehran, Iran, was poor (
63). In general, adherence to treatment can be affected by various factors, such as prescribed medications and mental, economic, and social factors. Therefore, understanding the psychosocial parameters affecting adherence to treatment among patients with chronic diseases and supporting them in those areas can be effective in their adherence to treatment regimens (
64). During the COVID-19 pandemic, the emergency services in Iran played an important role in the follow-up and therapeutic continuity of these elderly patients. Among the reasons for the difference in the results of the studies, it can be pointed to different demographic characteristics of patients in different studies, different levels of development and health literacy in the communities, and different tools used to check the level of treatment compliance of patients.
The present study findings showed no significant relationship between hope and adherence to the treatment regimen. Consistently, Alipour et al. emphasized that hope could not be a suitable mediator for adherence to the treatment regimen among patients with diabetes (
38). Habte et al. also showed the negative impact of hope on adherence to the treatment regimen. In other words, they regarded hope as an obstacle to the acceptance of antidiabetic drugs among some participants (
65). In contrast, Kavak and Yilmaz revealed a significant relationship between hope and adherence to treatment (
59). A study by Javanmardifard et al. showed that a significant reverse correlation was also observed between hope and adherence to treatment (
42). Overall, adherence to the treatment regimen might be affected by factors, such as attitude toward the disease, hope for the treatment of the disease, mildness of the disease, disease complications, easy application of the regimen, and its cost-effectiveness (
65). Considering the discrepancy among the results, further studies in this field are warranted.
The results of the present investigation revealed a significant relationship between happiness and adherence to the treatment regimen, which is in line with the findings of a study carried out by Cuffee et al. on patients suffering from hypertension. They mentioned that the patients with higher happiness levels showed better adherence to their treatment regimen (
66). The evidence has indicated that nonpathological emotional states, such as happiness, can result in psychological well-being, thereby exerting a profound effect on the incidence of health-related behaviors (
67). Since adherence to the treatment regimen is a health-related behavior, it can be positively affected by happiness. However, McDonald et al. stated that short-term interventions for the empowerment of patients’ happiness were not effective in the promotion of their adherence to treatment (
68), which is contrary to the findings of the current study. Therefore, long-term interventions for strengthening happiness, including the empowerment of interpersonal relationships, improvement of relationships between patients and their family members, and establishment of appropriate relationships between patients and society, have to be implemented among patients with chronic diseases in order to achieve the effect of happiness on adherence to treatment (
69).
Based on the results, adherence to treatment regimen and hope were not associated with demographic variables, which is consistent with the results of several studies conducted on the issue (
70). However, some studies have shown significant relationships between the aforementioned two variables and demographic features (
42). It seems that the relationship between the aforementioned variables and demographic characteristics depends on the type of the disease rather than the effect of the disease on patients and their quality of life.
The current study’s findings revealed a significant relationship between happiness and marital status. Similarly, Cheah and Tang reported significant relationships between happiness and some demographic features, such as marital status (
71). Generally, care and supportive relationships are vitally important among patients suffering from chronic diseases. Such support can be provided by family members, particularly the spouse, and can help individuals identify their capabilities and resources and succeed in coping with the disease (
72). Therefore, it can be concluded that during disease conditions, specifically chronic diseases, the presence of the spouse can be effective in increasing the elderly patient’s happiness level.
The findings of the current study also revealed a significant relationship between happiness and educational level, which is in agreement with the results obtained by Saffari et al. (
73). Delavar and Shokouhi Amirabadi showed there was a significant relationship between happiness and educational level of students during the COVID-19 period (
74). Education can play a pivotal role in choosing appropriate coping methods for reducing stress, improving psychological well-being, and solving problems associated with diseases. Therefore, higher educational levels can affect the selection of proper coping strategies against chronic diseases, eventually helping patients maintain their happiness as a component of psychological well-being.
5.1. Limitations
Considering the desirable cooperation on the part of the participants, the study suffered from no particular limitations. Nonetheless, due to the restrictions associated with the spread of the coronavirus, having access to older adult individuals was quite difficult and affected the study sample size. The completion of the study questionnaires electronically was also accompanied by several problems.
5.2. Conclusions
The participants in the current study had moderate levels of hope and happiness and showed good adherence to their treatment regimens. The results revealed no significant relationship between hope and adherence to the treatment regimen. However, a significant relationship was observed between happiness and adherence to the treatment regimen. Therefore, happiness as a psychological variable affecting psychological well-being can be effective in adherence to treatment among patients with chronic diseases. In this context, designing interventions for increasing happiness among these patients can affect their health-related behaviors, such as adherence to treatment, eventually improving their disease process and enhancing their quality of life. Therefore, measures should be taken to familiarize nursing students and healthcare personnel with these interventions in order to promote patients’ happiness levels. On the other hand, policymakers are recommended to develop programs to increase happiness among older adults who mostly suffer from chronic diseases. Based on the present study’s findings, increasing the happiness level can enhance adherence to the treatment regimen as a health-related behavior.